Investigation of hs-TnI and sST-2 as potential predictors of Long-Term Cardiovascular Risk in patients with survived hospitalization for COVID-19 pneumonia

L Fiedler, LJ Motloch, P Jirak, R Gumerov, P Davtyan… - Biomedicines, 2022 - mdpi.com
Introduction: COVID-19 survivors reveal an increased long-term risk for cardiovascular
disease. Biomarkers like troponins and sST-2 improve stratification of cardiovascular risk …

COVID-19 and pregnancy: an updated review about evidence-based therapeutic strategies

A Favilli, M Mattei Gentili, F De Paola… - Journal of Personalized …, 2023 - mdpi.com
The COVID-19 pandemic posed a significant challenge for clinicians in managing pregnant
women, who were at high risk of virus transmission and severe illness. While the WHO …

Glucocorticoid therapy in Covid-19

F Amati, A Tonutti, J Huston… - Seminars in Respiratory …, 2023 - thieme-connect.com
Coronavirus disease 2019 (COVID-19) pneumonia caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has resulted in significant mortality in pandemic …

COVID-19 in immunocompromised patients: a systematic review

A Stainer, F Amati, G Suigo, E Simonetta… - … in Respiratory and …, 2021 - thieme-connect.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was first identified as a
novel coronavirus in Wuhan, Hubei province, central China, in December 2019, and is …

Procalcitonin is not a reliable biomarker of bacterial coinfection in people with coronavirus disease 2019 undergoing microbiological investigation at the time of …

KA Relph, CD Russell, CJ Fairfield… - Open forum …, 2022 - academic.oup.com
Admission procalcitonin measurements and microbiology results were available for 1040
hospitalized adults with coronavirus disease 2019 (from 48 902 included in the International …

Intestinal damage in COVID-19: SARS-CoV-2 infection and intestinal thrombosis

X Wu, H Jing, C Wang, Y Wang, N Zuo… - Frontiers in …, 2022 - frontiersin.org
The intestinal tract, with high expression of angiotensin-converting enzyme 2 (ACE2), is a
major site of extrapulmonary infection in COVID-19. During pulmonary infection, the virus …

[HTML][HTML] Computational assessment of the nasal air conditioning and paranasal sinus ventilation from nasal assisted breathing therapy

M Khamooshi, DF Fletcher, H Salati, S Vahaji… - Physics of …, 2022 - pubs.aip.org
Nasal cannula oxygen therapy is a common treatment option for patients with respiratory
failure but needs further investigation to understand its potential for use for assisted …

Higher mortality and intubation rate in COVID-19 patients treated with noninvasive ventilation compared with high-flow oxygen or CPAP

S Marti, AE Carsin, J Sampol, M Pallero, I Aldas… - Scientific reports, 2022 - nature.com
The effectiveness of noninvasive respiratory support in severe COVID-19 patients is still
controversial. We aimed to compare the outcome of patients with COVID-19 pneumonia and …

Guideline-directed management of COVID-19: Do's and Don'ts

M Kolb, AT Dinh-Xuan… - European Respiratory …, 2021 - Eur Respiratory Soc
The coronavirus disease 2019 (COVID-19) pandemic continues to dominate our daily lives.
The “second wave” has slowed down in most regions around the globe, just to give way to …

Should we interfere with the interleukin-6 receptor during COVID-19: what do we know so far?

A Plocque, C Mitri, C Lefèvre, O Tabary, L Touqui… - Drugs, 2023 - Springer
Severe manifestations of COVID-19 consist of acute respiratory distress syndrome due to an
initially local reaction leading to a systemic inflammatory response that results in hypoxia …